AbCellera Biologics: Continuing To Expand Partnerships [Seeking Alpha]
AbCellera Biologics Inc. - Common Shares (ABCL)
Company Research
Source: Seeking Alpha
Analyst firms continue to Buy/Outperform ratings on the stock, but the company's partner pipeline is primarily very early-stage candidates. An updated analysis around AbCellera Biologics follows in the paragraphs below. Looking for a helping hand in the market? Members of The Biotech Forum get exclusive ideas and guidance to navigate any climate. Learn More » A mind all logic is like a knife all blade. It makes the hand bleed that uses it .”? Rabindranath Tagore. It has been nearly a year since we last took a look at AbCellera Biologics Inc. ( NASDAQ: ABCL . The company's revenue stream fell over a cliff thanks to the ebbing of the Covid pandemic. However, those sales helped the company build up a huge cash hoard. AbCellera continues to expand its wide range of partnerships across the drug developmental space. An update on this fairly unique concern follows below. Company Overview: AbCellera Biologics has built a platform for antibody drug discovery and development and is
Show less
Read more
Impact Snapshot
Event Time:
ABCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABCL alerts
High impacting AbCellera Biologics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ABCL
News
- Insider Stock Buying Reaches US$1.61m On AbCellera Biologics [Yahoo! Finance]Yahoo! Finance
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies [Yahoo! Finance]Yahoo! Finance
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesBusiness Wire
- Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]Yahoo! Finance
- Sky bridge to connect new state-of-the-art research facility to Vancouver's St. Paul's hospital [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
ABCL
Earnings
- 2/20/24 - Miss
ABCL
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- ABCL's page on the SEC website